[Impact of obesity and hypertension on left atrium size]

Xi Chen1, Jin-xiu Lin

  • 1Department of Cardiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

Insights

Obesity significantly impacts left atrial size more than hypertension. Combined obesity and hypertension show synergistic effects, leading to enlarged left atria in cardiovascular health studies.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Echocardiography
  • Integrative Physiology

Context:

  • Left atrial (LA) size is a critical indicator of cardiovascular health.
  • Obesity and hypertension are prevalent comorbidities affecting cardiac structure and function.
  • Understanding their independent and combined effects on LA size is crucial for risk stratification.

Purpose:

  • To investigate the independent and combined effects of obesity and hypertension on left atrial size.
  • To compare the impact of obesity versus hypertension on left atrial dimensions.
  • To determine the correlation between body mass index (BMI) and left atrial parameters.

Summary:

  • A study of 383 subjects categorized into normal, hypertension, obesity, and combined hypertension-obesity groups revealed significant differences in left atrial volume index (LAVI).
  • Obesity demonstrated a stronger correlation with LAVI (r=0.505) than systolic blood pressure (SBP) or diastolic blood pressure (DBP) (r=0.240, r=0.209).
  • Adjusted analyses confirmed BMI as a significant predictor of LAVI, with each unit increase associated with increased left atrial diameter, volume, and index.

Impact:

  • Obesity exerts a greater influence on left atrial enlargement than hypertension.
  • Obesity and hypertension act synergistically to increase left atrial size.
  • Findings highlight the substantial role of obesity in adverse cardiac remodeling, necessitating targeted interventions.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...